| Utestående aktier | 74,514,039 shares |
| Insideraktier | 18 721 522 shares |
| Insynsägande | 25,12 % |
| Totalt antal insynspersoner | 23 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
-2.051 %( )
11105 out of 11228Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Corvus Pharmaceuticals, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Adams Street Partners Llc
10% Owner -
|
126 806 | 126 806 | |
| Joseph J Buggy EVP Discovery Research - [O] | 617 496 | 617 496 | |
| Ian T Clark | 15 000 | ||
| Jason V Coloma | 0 | ||
|
EcoR1 Capital, LLC
10% Owner -
|
81 077 | 81 077 | |
|
Terry P Gould
Director, 10% Owner -
[D]
|
126 806 | 126 806 | |
| Linda S Grais Director - [D] | 10 000 | 10 000 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Hunt Daniel W. | 75 000 | ||
| Samuel D Isaly Director - [D] | 5 379 349 | 5 379 349 | |
| William Benton Jones See Remarks - [O] | 173 130 | 173 130 | |
| Krognes Steve E. | 15 000 | ||
| Leiv Lea Chief Financial Officer - [O] | 282 444 | 282 444 | |
| Richard A Md Miller President and CEO, Director - [D] [O] | 1 136 707 | 1 136 707 | |
| Mitchell Edith P. | 15 000 | ||
| Mehrdad Mobasher | 85 000 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Peter Moldt | 0 | ||
| Scott W Morrison | 15 000 | ||
|
A/S Novo
10% Owner -
|
1 389 498 | 1 389 498 | |
|
Orbimed Advisors Llc
Director, 10% Owner -
[D]
|
7 165 006 | 7 165 006 | |
| OrbiMed Capital GP V LLC Director - [D] | 6 943 654 | 7 165 006 | |
|
Thompson Peter A.
Director, 10% Owner -
[D]
|
7 165 006 | 7 165 006 | |
| Verner Erik J. V.P., Chemistry Research - [O] | 127 546 | 127 546 | |
| den Broek Richard van Director - [D] | 320 000 | 320 000 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i CRVS / Corvus Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i CRVS / Corvus Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-01 | 2025-06-27 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock | I | 4,1586 | −1 176 332 | −4 892 | 7 165 006 | ||||
| 2025-07-01 | 2025-06-27 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock | I | 3,5000 | 1 397 684 | 4 892 | 8 341 338 | ||||
| 2025-07-01 | 2025-06-27 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock | I | 4,1586 | −1 176 332 | −4 892 | 7 165 006 | ||||
| 2025-07-01 | 2025-06-27 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock | I | 3,5000 | 1 397 684 | 4 892 | 8 341 338 | ||||
| 2025-06-06 | 2025-06-04 | 4 | Jones William Benton | CRVS | Common Stock | D | 3,5000 | 19 357 | 68 | 173 130 | ||||
| 2025-05-09 | 2025-05-07 | 4 | MILLER RICHARD A MD | CRVS | Common Stock | D | 3,5000 | 559 073 | 1 957 | 1 136 707 | ||||
| 2025-04-09 | 3 | van den Broek Richard See foonote | CRVS | Common Stock | I | 160 000 | ||||||||
| 2024-05-14 | 2024-05-10 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock | I | −302 016 | 1 188 103 | ||||||
| 2024-05-07 | 2024-05-06 | 4 | Jones William Benton | CRVS | Common Stock | D | 1,7312 | 20 000 | 35 | 153 773 | ||||
| 2024-05-07 | 2024-05-06 | 4 | MILLER RICHARD A MD | CRVS | Common Stock | D | 1,7312 | 577 634 | 1 000 | 577 634 | ||||
| 2023-05-16 | 2023-05-15 | 4 | Grais Linda S | CRVS | Common Stock | D | 2,4500 | 10 000 | 24 | 10 000 | ||||
| 2022-12-20 | 2022-12-20 | 4 | Jones William Benton | CRVS | Common Stock | D | 0,7900 | 20 000 | 16 | 133 773 | ||||
| 2022-12-15 | 2022-12-14 | 4 | LEA LEIV By IRA | CRVS | Common Stock | I | 0,8410 | 4 000 | 3 | 133 238 | ||||
| 2022-12-15 | 2022-12-13 | 4 | LEA LEIV By IRA | CRVS | Common Stock | I | 0,7425 | 30 000 | 22 | 129 238 | ||||
| 2022-12-15 | 2022-12-14 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock | I | 0,7812 | 10 000 | 8 | 1 490 119 | ||||
| 2022-12-15 | 2022-12-13 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock | I | 0,7403 | 50 000 | 37 | 1 480 119 | ||||
| 2022-09-28 | 2022-09-28 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock | I | 0,7628 | 25 000 | 19 | 1 394 405 | ||||
| 2022-09-20 | 2022-09-20 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock | I | 0,8150 | 5 000 | 4 | 1 369 405 | ||||
| 2022-09-20 | 2022-09-20 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock | I | 0,8200 | 2 700 | 2 | 1 364 405 | ||||
| 2022-09-20 | 2022-09-20 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock | I | 0,8101 | 12 300 | 10 | 1 361 705 | ||||
| 2022-06-28 | 2022-06-27 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock | I | 0,9969 | 5 000 | 5 | 1 349 405 | ||||
| 2022-06-28 | 2022-06-24 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock | I | 1,0300 | 5 000 | 5 | 1 344 405 | ||||
| 2022-06-06 | 2022-06-06 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock | I | 1,0100 | 890 | 1 | 1 339 405 | ||||
| 2022-06-06 | 2022-06-02 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock | I | 0,9700 | 170 | 0 | 1 338 515 | ||||
| 2022-06-06 | 2022-06-02 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock | I | 0,9800 | 4 830 | 5 | 1 338 345 | ||||
| 2022-04-01 | 2022-03-31 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock | I | 1,6356 | 15 000 | 25 | 1 333 515 | ||||
| 2022-03-17 | 2022-03-17 | 4 | LEA LEIV By IRA | CRVS | Common Stock | I | 1,6500 | 13 878 | 23 | 99 238 | ||||
| 2022-03-17 | 2022-03-16 | 4 | LEA LEIV By IRA | CRVS | Common Stock | I | 1,5400 | 35 160 | 54 | 85 360 | ||||
| 2022-03-17 | 2022-03-17 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock | I | 1,5900 | 5 000 | 8 | 1 318 515 | ||||
| 2022-03-17 | 2022-03-15 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock | I | 1,4660 | 25 000 | 37 | 1 313 515 | ||||
| 2021-10-01 | 2021-10-01 | 4 | EcoR1 Capital, LLC See Note 2 | CRVS | Common Stock | I | 4,9644 | −2 000 000 | −9 929 | 81 077 | ||||
| 2021-10-01 | 2021-09-30 | 4 | EcoR1 Capital, LLC See Note 2 | CRVS | Common Stock | I | 5,0437 | −3 000 000 | −15 131 | 2 081 077 | ||||
| 2021-09-22 | 2021-09-20 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 6,0900 | −1 109 644 | −6 758 | 6 943 654 | ||||
| 2021-09-22 | 2021-09-20 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 6,0900 | −1 109 644 | −6 758 | 6 943 654 | ||||
| 2021-09-22 | 3 | EcoR1 Capital, LLC See Notes 1 and 2 | CRVS | Common Stock | I | 5 081 077 | ||||||||
| 2021-09-13 | 2021-09-09 | 4 | MILLER RICHARD A MD | CRVS | Stock Option (Right to Buy) | D | 2,60 | 320 000 | 320 000 | |||||
| 2021-09-13 | 2021-09-09 | 4 | LEA LEIV | CRVS | Stock Option (Right to Buy) | D | 2,60 | 160 000 | 160 000 | |||||
| 2021-09-13 | 2021-09-09 | 4 | Jones William Benton | CRVS | Stock Option (Right to Buy) | D | 2,60 | 160 000 | 160 000 | |||||
| 2021-09-13 | 2021-09-09 | 4 | Grais Linda S | CRVS | Stock Option (Right to Buy) | D | 2,60 | 15 000 | 15 000 | |||||
| 2021-09-13 | 2021-09-09 | 4 | Mitchell Edith P. | CRVS | Stock Option (Right to Buy) | D | 2,60 | 15 000 | 15 000 | |||||
| 2021-09-13 | 2021-09-09 | 4 | Gould Terry P | CRVS | Stock Option (Right to Buy) | D | 2,60 | 15 000 | 15 000 | |||||
| 2021-09-13 | 2021-09-09 | 4 | Thompson Peter A. | CRVS | Stock Option (Right to Buy) | D | 2,60 | 15 000 | 15 000 | |||||
| 2021-09-13 | 2021-09-09 | 4 | Morrison Scott W | CRVS | Stock Option (Right to Buy) | D | 2,60 | 15 000 | 15 000 | |||||
| 2021-09-13 | 2021-09-09 | 4 | CLARK IAN T | CRVS | Stock Option (Right to Buy) | D | 2,60 | 15 000 | 15 000 | |||||
| 2021-09-13 | 2021-09-09 | 4 | ADAMS STREET PARTNERS LLC | CRVS | Stock Option (Right to Buy) | I | 2,60 | 15 000 | 15 000 | |||||
| 2021-08-23 | 2021-08-20 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock | I | 1,9254 | 10 000 | 19 | 1 288 515 | ||||
| 2021-06-16 | 2021-06-15 | 4 | Grais Linda S | CRVS | Stock Option (Right to Buy) | D | 2,74 | 15 000 | 15 000 | |||||
| 2021-06-16 | 2021-06-15 | 4 | Mitchell Edith P. | CRVS | Stock Option (Right to Buy) | D | 2,74 | 15 000 | 15 000 | |||||
| 2021-06-16 | 2021-06-15 | 4 | CLARK IAN T | CRVS | Stock Option (Right to Buy) | D | 2,74 | 15 000 | 15 000 | |||||
| 2021-06-16 | 2021-06-15 | 4 | Morrison Scott W | CRVS | Stock Option (Right to Buy) | D | 2,74 | 15 000 | 15 000 | |||||
| 2021-06-16 | 2021-06-15 | 4 | Thompson Peter A. | CRVS | Stock Option (Right to Buy) | D | 2,74 | 15 000 | 15 000 | |||||
| 2021-06-16 | 2021-06-15 | 4 | ADAMS STREET PARTNERS LLC | CRVS | Stock Option (Right to Buy) | I | 2,74 | 15 000 | 15 000 | |||||
| 2021-06-16 | 2021-06-15 | 4 | Gould Terry P | CRVS | Stock Option (Right to Buy) | D | 2,74 | 15 000 | 15 000 | |||||
| 2021-05-05 | 2021-05-04 | 4 | MILLER RICHARD A MD | CRVS | Common Stock | D | 2,8000 | 35 714 | 100 | 35 714 | ||||
| 2021-02-19 | 2021-02-17 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 3,5000 | 1 285 714 | 4 500 | 8 053 298 | ||||
| 2021-02-19 | 2021-02-17 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 3,5000 | 1 285 714 | 4 500 | 8 053 298 | ||||
| 2021-02-17 | 2021-02-17 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock | I | 3,5000 | 100 000 | 350 | 1 278 515 | ||||
| 2020-12-17 | 2020-12-16 | 4 | Jones William Benton | CRVS | Stock Option (Right to Buy) | D | 4,01 | 160 000 | 160 000 | |||||
| 2020-12-17 | 2020-12-16 | 4 | LEA LEIV | CRVS | Stock Option (Right to Buy) | D | 4,01 | 160 000 | 160 000 | |||||
| 2020-12-17 | 2020-12-16 | 4 | Mobasher Mehrdad | CRVS | Stock Option (Right to Buy) | D | 4,01 | 85 000 | 85 000 | |||||
| 2020-12-17 | 2020-12-16 | 4 | MILLER RICHARD A MD | CRVS | Stock Option (Right to Buy) | D | 4,01 | 320 000 | 320 000 | |||||
| 2020-09-15 | 2020-09-10 | 4 | Mitchell Edith P. | CRVS | Stock Option (Right to Buy) | D | 3,95 | 30 000 | 30 000 | |||||
| 2020-07-09 | 2020-07-08 | 4 | Novo A/S | CRVS | COMMON STOCK | D | 5,3749 | −741 440 | −3 985 | 1 389 498 | ||||
| 2020-07-09 | 2020-07-07 | 4 | Novo A/S | CRVS | COMMON STOCK | D | 5,2514 | −796 622 | −4 183 | 2 130 938 | ||||
| 2020-06-15 | 2020-06-09 | 4 | ADAMS STREET PARTNERS LLC | CRVS | Stock Option (Right to Buy) | I | 3,27 | 15 000 | 15 000 | |||||
| 2020-06-12 | 2020-06-09 | 4 | Grais Linda S | CRVS | Stock Option (Right to Buy) | D | 3,27 | 15 000 | 15 000 | |||||
| 2020-06-12 | 2020-06-09 | 4 | Gould Terry P | CRVS | Stock Option (Right to Buy) | D | 3,27 | 15 000 | 15 000 | |||||
| 2020-06-12 | 2020-06-09 | 4 | Krognes Steve E. | CRVS | Stock Option (Right to Buy) | D | 3,27 | 15 000 | 15 000 | |||||
| 2020-06-12 | 2020-06-09 | 4 | Morrison Scott W | CRVS | Stock Option (Right to Buy) | D | 3,27 | 15 000 | 15 000 | |||||
| 2020-06-12 | 2020-06-09 | 4 | Thompson Peter A. | CRVS | Stock Option (Right to Buy) | D | 3,27 | 15 000 | 15 000 | |||||
| 2020-06-12 | 2020-06-09 | 4 | CLARK IAN T | CRVS | Stock Option (Right to Buy) | D | 3,27 | 15 000 | 15 000 | |||||
| 2020-05-06 | 3 | Novo A/S | CRVS | COMMON STOCK | D | 5 855 120 | ||||||||
| 2020-05-06 | 3 | Novo A/S | CRVS | COMMON STOCK | D | 5 855 120 | ||||||||
| 2020-05-06 | 3 | Novo A/S | CRVS | COMMON STOCK | D | 5 855 120 | ||||||||
| 2020-03-23 | 2020-03-19 | 4 | Gould Terry P | CRVS | Stock Option (Right to Buy) | D | 2,00 | 15 000 | 15 000 | |||||
| 2020-03-23 | 2020-03-19 | 4 | Thompson Peter A. | CRVS | Stock Option (Right to Buy) | D | 2,00 | 15 000 | 15 000 | |||||
| 2020-03-23 | 2020-03-19 | 4 | Morrison Scott W | CRVS | Stock Option (Right to Buy) | D | 2,00 | 15 000 | 15 000 | |||||
| 2020-03-23 | 2020-03-19 | 4 | Krognes Steve E. | CRVS | Stock Option (Right to Buy) | D | 2,00 | 15 000 | 15 000 | |||||
| 2020-03-23 | 2020-03-19 | 4 | CLARK IAN T | CRVS | Stock Option (Right to Buy) | D | 2,00 | 15 000 | 15 000 | |||||
| 2020-03-23 | 2020-03-19 | 4 | Grais Linda S | CRVS | Stock Option (Right to Buy) | D | 2,00 | 15 000 | 15 000 | |||||
| 2020-03-23 | 2020-03-19 | 4 | ADAMS STREET PARTNERS LLC | CRVS | Stock Option (Right to Buy) | I | 2,00 | 15 000 | 15 000 | |||||
| 2019-12-16 | 2019-12-12 | 4 | Buggy Joseph J | CRVS | Stock Option (Right to Buy) | D | 3,54 | 40 000 | 40 000 | |||||
| 2019-12-16 | 2019-12-12 | 4 | Hunt Daniel W. | CRVS | Stock Option (Right to Buy) | D | 3,54 | 75 000 | 75 000 | |||||
| 2019-12-16 | 2019-12-12 | 4 | Jones William Benton | CRVS | Stock Option (Right to Buy) | D | 3,54 | 160 000 | 160 000 | |||||
| 2019-12-16 | 2019-12-12 | 4 | LEA LEIV | CRVS | Stock Option (Right to Buy) | D | 3,54 | 160 000 | 160 000 | |||||
| 2019-12-16 | 2019-12-12 | 4 | MILLER RICHARD A MD | CRVS | Stock Option (Right to Buy) | D | 3,54 | 320 000 | 320 000 | |||||
| 2019-12-16 | 2019-12-12 | 4 | Mobasher Mehrdad | CRVS | Stock Option (Right to Buy) | D | 3,54 | 50 000 | 50 000 | |||||
| 2019-12-16 | 2019-12-12 | 4 | Verner Erik J. | CRVS | Stock Option (Right to Buy) | D | 3,54 | 50 000 | 50 000 | |||||
| 2019-11-14 | 2019-11-13 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock | I | 3,0022 | 14 736 | 44 | 1 178 515 | ||||
| 2019-11-14 | 2019-11-12 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock | I | 2,9000 | 272 | 1 | 1 163 779 | ||||
| 2019-08-08 | 2019-08-06 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 3,5100 | 142 656 | 501 | 6 767 584 | ||||
| 2019-08-08 | 2019-08-06 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 3,5100 | 142 656 | 501 | 6 767 584 | ||||
| 2019-08-08 | 2019-08-07 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 3,5400 | 2 500 | 9 | 1 163 507 | ||||
| 2019-08-08 | 2019-08-06 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 3,5750 | 5 000 | 18 | 1 161 007 | ||||
| 2019-07-25 | 2019-07-25 | 4 | Novo A/S | CRVS | COMMON STOCK | D | 4,0000 | −1 400 000 | −5 600 | 2 927 560 | ||||
| 2019-07-25 | 2019-07-24 | 4 | Novo A/S | CRVS | COMMON STOCK | D | 5,0096 | −53 240 | −267 | 4 327 560 | ||||
| 2019-07-25 | 2019-07-23 | 4 | Novo A/S | CRVS | COMMON STOCK | D | 5,3161 | −39 716 | −211 | 4 380 800 | ||||
| 2019-07-01 | 2019-07-01 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 3,9100 | 59 243 | 232 | 6 624 928 | ||||
| 2019-07-01 | 2019-06-28 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 3,7200 | 565 178 | 2 102 | 6 565 685 | ||||
| 2019-07-01 | 2019-06-27 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 3,3400 | 32 923 | 110 | 6 000 507 | ||||
| 2019-07-01 | 2019-07-01 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 3,9100 | 59 243 | 232 | 6 624 928 | ||||
| 2019-07-01 | 2019-06-28 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 3,7200 | 565 178 | 2 102 | 6 565 685 | ||||
| 2019-07-01 | 2019-06-27 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 3,3400 | 32 923 | 110 | 6 000 507 | ||||
| 2019-06-24 | 2019-06-20 | 4 | Krognes Steve E. | CRVS | Stock Option (Right to Buy) | D | 3,61 | 15 000 | 15 000 | |||||
| 2019-06-24 | 2019-06-20 | 4 | ADAMS STREET PARTNERS LLC | CRVS | Stock Option (Right to Buy) | I | 3,61 | 15 000 | 15 000 | |||||
| 2019-06-24 | 2019-06-20 | 4 | CLARK IAN T | CRVS | Stock Option (Right to Buy) | D | 3,61 | 15 000 | 15 000 | |||||
| 2019-06-24 | 2019-06-20 | 4 | Thompson Peter A. | CRVS | Stock Option (Right to Buy) | D | 3,61 | 15 000 | 15 000 | |||||
| 2019-06-24 | 2019-06-20 | 4 | Grais Linda S | CRVS | Stock Option (Right to Buy) | D | 3,61 | 15 000 | 15 000 | |||||
| 2019-06-24 | 2019-06-20 | 4 | Gould Terry P | CRVS | Stock Option (Right to Buy) | D | 3,61 | 15 000 | 15 000 | |||||
| 2019-06-24 | 2019-06-20 | 4 | Morrison Scott W | CRVS | Stock Option (Right to Buy) | D | 3,61 | 15 000 | 15 000 | |||||
| 2019-06-17 | 2019-06-14 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 3,4028 | 11 657 | 40 | 1 156 007 | ||||
| 2019-06-17 | 2019-06-13 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 3,5200 | 343 | 1 | 1 144 350 | ||||
| 2019-06-11 | 2019-06-11 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 3,6700 | 6 000 | 22 | 1 144 007 | ||||
| 2019-06-11 | 2019-06-07 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 3,3672 | 9 212 | 31 | 1 138 007 | ||||
| 2019-06-10 | 2019-06-07 | 4 | LEA LEIV By IRA | CRVS | Common Stock, $0.0001 par value | I | 3,3800 | 10 000 | 34 | 50 200 | ||||
| 2019-06-10 | 2019-06-06 | 4 | LEA LEIV By IRA | CRVS | Common Stock, $0.0001 par value | I | 3,5600 | 15 500 | 55 | 40 200 | ||||
| 2019-01-30 | 2019-01-28 | 4 | Mobasher Mehrdad | CRVS | Stock Option (Right to Buy) | D | 3,88 | 210 000 | 210 000 | |||||
| 2019-01-30 | 2019-01-28 | 4 | Grais Linda S | CRVS | Stock Option (Right to Buy) | D | 3,88 | 30 000 | 30 000 | |||||
| 2018-12-31 | 2018-12-27 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 3,2942 | 20 000 | 66 | 1 128 795 | ||||
| 2018-12-27 | 2018-12-21 | 4 | LEA LEIV By IRA | CRVS | Common Stock, $0.0001 par value | I | 4,1461 | 24 700 | 102 | 24 700 | ||||
| 2018-12-26 | 2018-12-20 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 4,3900 | 5 000 | 22 | 1 108 795 | ||||
| 2018-12-26 | 2018-12-20 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 4,4000 | 5 000 | 22 | 1 103 795 | ||||
| 2018-12-14 | 2018-12-12 | 4 | Verner Erik J. | CRVS | Stock Option (Right to Buy) | D | 5,94 | −50 000 | 50 000 | |||||
| 2018-12-14 | 2018-12-12 | 4 | Hunt Daniel W. | CRVS | Stock Option (Right to Buy) | D | 5,94 | −50 000 | 50 000 | |||||
| 2018-12-14 | 2018-12-12 | 4 | LEA LEIV | CRVS | Stock Option (Right to Buy) | D | 5,94 | 100 000 | 100 000 | |||||
| 2018-12-14 | 2018-12-12 | 4 | Buggy Joseph J | CRVS | Stock Option (Right to Buy) | D | 5,94 | 100 000 | 100 000 | |||||
| 2018-12-14 | 2018-12-12 | 4 | MILLER RICHARD A MD | CRVS | Stock Option (Right to Buy) | D | 5,94 | 250 000 | 250 000 | |||||
| 2018-12-14 | 2018-12-11 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | −10 000 | 1 098 795 | ||||||
| 2018-12-14 | 2018-12-11 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | −10 000 | 1 098 795 | ||||||
| 2018-12-14 | 2018-12-12 | 4 | Jones William Benton | CRVS | Stock Option (Right to Buy) | D | 5,94 | 100 000 | 100 000 | |||||
| 2018-12-10 | 2018-12-06 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 5,9868 | 5 000 | 30 | 1 118 795 | ||||
| 2018-12-06 | 2018-12-04 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 5,9500 | 1 502 | 9 | 1 113 795 | ||||
| 2018-06-25 | 2018-06-21 | 4 | Krognes Steve E. | CRVS | Stock Option (Right to Buy) | D | 12,50 | 15 000 | 15 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | CLARK IAN T | CRVS | Stock Option (Right to Buy) | D | 12,50 | 15 000 | 15 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | Gould Terry P | CRVS | Stock Option (Right to Buy) | D | 12,50 | 15 000 | 15 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | Morrison Scott W | CRVS | Stock Option (Right to Buy) | D | 12,50 | 15 000 | 15 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | Thompson Peter A. | CRVS | Stock Option (Right to Buy) | D | 12,50 | 15 000 | 15 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | ADAMS STREET PARTNERS LLC | CRVS | Stock Option (Right to Buy) | I | 12,50 | 15 000 | 15 000 | |||||
| 2018-03-14 | 2018-03-12 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 8,5000 | 588 235 | 5 000 | 5 967 584 | ||||
| 2018-03-14 | 2018-03-12 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 8,5000 | 588 235 | 5 000 | 5 967 584 | ||||
| 2018-03-13 | 2018-03-12 | 4 | Novo A/S | CRVS | COMMON STOCK | D | 8,5000 | 1 176 470 | 10 000 | 4 420 516 | ||||
| 2018-03-13 | 2018-03-12 | 4 | Gould Terry P By Fund | CRVS | Common Stock, $0.0001 par value | I | 8,5000 | 126 806 | 1 078 | 126 806 | ||||
| 2018-03-13 | 2018-03-12 | 4 | Gould Terry P By Fund | CRVS | Common Stock, $0.0001 par value | I | 8,5000 | 87 668 | 745 | 87 668 | ||||
| 2018-03-13 | 2018-03-12 | 4 | Gould Terry P By Fund | CRVS | Common Stock, $0.0001 par value | I | 8,5000 | 67 769 | 576 | 67 769 | ||||
| 2018-03-13 | 2018-03-12 | 4 | Gould Terry P By Fund | CRVS | Common Stock, $0.0001 par value | I | 8,5000 | 236 128 | 2 007 | 236 128 | ||||
| 2018-03-13 | 2018-03-12 | 4 | Gould Terry P By Fund | CRVS | Common Stock, $0.0001 par value | I | 8,5000 | 69 864 | 594 | 69 864 | ||||
| 2018-03-13 | 2018-03-12 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Common Stock, $0.0001 par value | I | 8,5000 | 126 806 | 1 078 | 126 806 | ||||
| 2018-03-13 | 2018-03-12 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Common Stock, $0.0001 par value | I | 8,5000 | 87 668 | 745 | 87 668 | ||||
| 2018-03-13 | 2018-03-12 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Common Stock, $0.0001 par value | I | 8,5000 | 67 769 | 576 | 67 769 | ||||
| 2018-03-13 | 2018-03-12 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Common Stock, $0.0001 par value | I | 8,5000 | 236 128 | 2 007 | 236 128 | ||||
| 2018-03-13 | 2018-03-12 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Common Stock, $0.0001 par value | I | 8,5000 | 69 864 | 594 | 69 864 | ||||
| 2018-03-12 | 2018-03-12 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 8,5000 | 100 000 | 850 | 1 112 293 | ||||
| 2018-01-23 | 3 | Buggy Joseph J | CRVS | Common Stock, $0.0001 par value | D | 436 062 | ||||||||
| 2018-01-23 | 3 | Buggy Joseph J By Trust | CRVS | Common Stock, $0.0001 par value | I | 617 496 | ||||||||
| 2018-01-23 | 3 | Buggy Joseph J | CRVS | Common Stock, $0.0001 par value | D | 436 062 | ||||||||
| 2018-01-23 | 3 | Buggy Joseph J By Trust | CRVS | Common Stock, $0.0001 par value | I | 617 496 | ||||||||
| 2018-01-23 | 2018-01-19 | 4 | Buggy Joseph J | CRVS | Stock Option (Right to Buy) | D | 9,94 | 100 000 | 100 000 | |||||
| 2017-12-15 | 2017-12-13 | 4 | MILLER RICHARD A MD | CRVS | Stock Option (Right to Buy) | D | 10,60 | 125 000 | 125 000 | |||||
| 2017-12-15 | 2017-12-13 | 4 | LEA LEIV | CRVS | Stock Option (Right to Buy) | D | 10,60 | 40 000 | 40 000 | |||||
| 2017-12-15 | 2017-12-13 | 4 | Hunt Daniel W. | CRVS | Stock Option (Right to Buy) | D | 10,60 | 200 000 | 200 000 | |||||
| 2017-12-15 | 2017-12-13 | 4 | Jones William Benton | CRVS | Stock Option (Right to Buy) | D | 10,60 | 40 000 | 40 000 | |||||
| 2017-12-15 | 2017-12-13 | 4 | Verner Erik J. | CRVS | Stock Option (Right to Buy) | D | 10,60 | 25 000 | 25 000 | |||||
| 2017-11-22 | 2017-11-20 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 10,7850 | 10 000 | 108 | 1 012 293 | ||||
| 2017-06-27 | 2017-06-23 | 4 | Novo A/S | CRVS | COMMON STOCK | D | 10,9500 | 20 000 | 219 | 3 244 046 | ||||
| 2017-06-13 | 2017-06-13 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 10,1400 | 2 500 | 25 | 1 002 293 | ||||
| 2017-06-13 | 2017-06-13 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 9,7500 | 2 500 | 24 | 999 793 | ||||
| 2017-06-13 | 2017-06-12 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 9,8239 | 11 216 | 110 | 997 293 | ||||
| 2017-06-13 | 2017-06-09 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 9,8900 | 3 784 | 37 | 986 077 | ||||
| 2017-06-13 | 2017-06-09 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 9,9500 | 5 000 | 50 | 982 293 | ||||
| 2017-06-09 | 2017-06-08 | 4 | Morrison Scott W | CRVS | Stock Option (Right to Buy) | D | 9,70 | 15 000 | 15 000 | |||||
| 2017-06-09 | 2017-06-08 | 4 | CLARK IAN T | CRVS | Stock Option (Right to Buy) | D | 9,70 | 15 000 | 15 000 | |||||
| 2017-06-09 | 2017-06-08 | 4 | Krognes Steve E. | CRVS | Stock Option (Right to Buy) | D | 9,70 | 15 000 | 15 000 | |||||
| 2017-06-09 | 2017-06-08 | 4 | Thompson Peter A. | CRVS | Stock Option (Right to Buy) | D | 9,70 | 15 000 | 15 000 | |||||
| 2017-06-09 | 2017-06-08 | 4 | Gould Terry P | CRVS | Stock Option (Right to Buy) | D | 9,70 | 15 000 | 15 000 | |||||
| 2017-06-09 | 2017-06-08 | 4 | ADAMS STREET PARTNERS LLC See Footnotes | CRVS | Stock Option (Right to Buy) | I | 9,70 | 15 000 | 15 000 | |||||
| 2017-02-10 | 2016-10-28 | 5 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | −50 000 | 977 293 | ||||||
| 2017-02-10 | 2016-10-28 | 5 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | −50 000 | 1 027 293 | ||||||
| 2017-02-10 | 2016-08-25 | 5 | LEA LEIV By Trust | CRVS | Common Stock, $0.0001 par value | I | −2 047 | 149 206 | ||||||
| 2017-02-10 | 2016-08-25 | 5 | LEA LEIV By Trust | CRVS | Common Stock, $0.0001 par value | I | −48 000 | 151 253 | ||||||
| 2017-01-04 | 2017-01-03 | 4 | CLARK IAN T | CRVS | Stock Option (Right to Buy) | D | 14,43 | 30 000 | 30 000 | |||||
| 2016-12-08 | 2016-12-07 | 4 | MILLER RICHARD A MD | CRVS | Stock Option (Right to Buy) | D | 16,37 | 160 000 | 160 000 | |||||
| 2016-12-08 | 2016-12-07 | 4 | Verner Erik J. | CRVS | Stock Option (Right to Buy) | D | 16,37 | 25 000 | 25 000 | |||||
| 2016-12-08 | 2016-12-07 | 4 | Jones William Benton | CRVS | Stock Option (Right to Buy) | D | 16,37 | 25 000 | 25 000 | |||||
| 2016-12-08 | 2016-12-07 | 4 | LEA LEIV | CRVS | Stock Option (Right to Buy) | D | 16,37 | 25 000 | 25 000 | |||||
| 2016-06-27 | 2016-06-24 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 12,9900 | 900 | 12 | 5 379 349 | ||||
| 2016-06-27 | 2016-06-23 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 12,9200 | 100 | 1 | 5 378 449 | ||||
| 2016-06-27 | 2016-06-24 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 12,9900 | 900 | 12 | 5 379 349 | ||||
| 2016-06-27 | 2016-06-23 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 12,9200 | 100 | 1 | 5 378 449 | ||||
| 2016-06-21 | 2016-06-21 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 12,8700 | 26 083 | 336 | 5 378 349 | ||||
| 2016-06-21 | 2016-06-17 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 12,4800 | 12 300 | 154 | 5 352 266 | ||||
| 2016-06-21 | 2016-06-21 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 12,8700 | 26 083 | 336 | 5 378 349 | ||||
| 2016-06-21 | 2016-06-17 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 12,4800 | 12 300 | 154 | 5 352 266 | ||||
| 2016-06-16 | 2016-06-16 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 12,0400 | 5 000 | 60 | 5 339 966 | ||||
| 2016-06-16 | 2016-06-15 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 11,9400 | 5 000 | 60 | 5 334 966 | ||||
| 2016-06-16 | 2016-06-14 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 12,7100 | 10 000 | 127 | 5 329 966 | ||||
| 2016-06-16 | 2016-06-16 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 12,0400 | 5 000 | 60 | 5 339 966 | ||||
| 2016-06-16 | 2016-06-15 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 11,9400 | 5 000 | 60 | 5 334 966 | ||||
| 2016-06-16 | 2016-06-14 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 12,7100 | 10 000 | 127 | 5 329 966 | ||||
| 2016-06-13 | 2016-06-10 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 12,9800 | 20 000 | 260 | 5 319 966 | ||||
| 2016-06-13 | 2016-06-09 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 12,9500 | 30 000 | 388 | 5 299 966 | ||||
| 2016-06-13 | 2016-06-10 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 12,9800 | 20 000 | 260 | 5 319 966 | ||||
| 2016-06-13 | 2016-06-09 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 12,9500 | 30 000 | 388 | 5 299 966 | ||||
| 2016-06-10 | 2016-06-08 | 4 | Coloma Jason V | CRVS | Stock Option (Right to Buy) | D | 13,34 | 200 000 | 200 000 | |||||
| 2016-05-24 | 2016-05-20 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 13,0900 | 4 716 | 62 | 5 269 966 | ||||
| 2016-05-24 | 2016-05-20 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 13,0900 | 4 716 | 62 | 5 269 966 | ||||
| 2016-05-20 | 2016-05-19 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 12,7500 | 61 | 1 | 5 265 250 | ||||
| 2016-05-20 | 2016-05-19 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 12,1100 | 2 539 | 31 | 5 265 189 | ||||
| 2016-05-20 | 2016-05-18 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 11,5500 | 4 200 | 49 | 5 262 650 | ||||
| 2016-05-20 | 2016-05-19 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 12,7500 | 61 | 1 | 5 265 250 | ||||
| 2016-05-20 | 2016-05-19 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 12,1100 | 2 539 | 31 | 5 265 189 | ||||
| 2016-05-20 | 2016-05-18 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 11,5500 | 4 200 | 49 | 5 262 650 | ||||
| 2016-05-16 | 2016-05-13 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 9,9367 | 300 | 3 | 1 077 293 | ||||
| 2016-05-16 | 2016-05-12 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 10,0000 | 30 000 | 300 | 1 076 993 | ||||
| 2016-05-16 | 2016-05-12 | 4 | Novo A/S | CRVS | COMMON STOCK | D | 10,0000 | 70 000 | 700 | 3 224 046 | ||||
| 2016-03-30 | 2016-03-29 | 4 | Novo A/S | CRVS | Series B Preferred Stock | D | −356 888 | 0 | ||||||
| 2016-03-30 | 2016-03-29 | 4 | Novo A/S | CRVS | Series A Preferred Stock | D | −2 130 492 | 0 | ||||||
| 2016-03-30 | 2016-03-29 | 4 | Novo A/S | CRVS | Common Stock | D | 15,0000 | 666 666 | 10 000 | 3 154 046 | ||||
| 2016-03-30 | 2016-03-29 | 4 | Novo A/S | CRVS | Common Stock | D | 356 888 | 2 487 380 | ||||||
| 2016-03-30 | 2016-03-29 | 4 | Novo A/S | CRVS | Common Stock | D | 2 130 492 | 2 130 492 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | Gould Terry P By Fund | CRVS | Series B Convertible Preferred Stock | I | −97 746 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | Gould Terry P By Fund | CRVS | Series A Convertible Preferred Stock | I | −583 510 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | Gould Terry P By Fund | CRVS | Series B Convertible Preferred Stock | I | −71 863 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | Gould Terry P By Fund | CRVS | Series A Convertible Preferred Stock | I | −428 998 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | Gould Terry P By Fund | CRVS | Series B Convertible Preferred Stock | I | −95 001 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | Gould Terry P By Fund | CRVS | Series A Convertible Preferred Stock | I | −567 121 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | Gould Terry P By Fund | CRVS | Series B Convertible Preferred Stock | I | −92 278 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | Gould Terry P By Fund | CRVS | Series A Convertible Preferred Stock | I | −550 864 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | Gould Terry P By Fund | CRVS | Common Stock, $0.0001 par value | I | 15,0000 | 54 777 | 822 | 736 033 | ||||
| 2016-03-29 | 2016-03-29 | 4 | Gould Terry P By Fund | CRVS | Common Stock, $0.0001 par value | I | 97 746 | 681 256 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | Gould Terry P By Fund | CRVS | Common Stock, $0.0001 par value | I | 583 510 | 583 510 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | Gould Terry P By Fund | CRVS | Common Stock, $0.0001 par value | I | 15,0000 | 40 272 | 604 | 541 133 | ||||
| 2016-03-29 | 2016-03-29 | 4 | Gould Terry P By Fund | CRVS | Common Stock, $0.0001 par value | I | 71 863 | 500 861 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | Gould Terry P By Fund | CRVS | Common Stock, $0.0001 par value | I | 428 998 | 428 998 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | Gould Terry P By Fund | CRVS | Common Stock, $0.0001 par value | I | 15,0000 | 53 239 | 799 | 715 361 | ||||
| 2016-03-29 | 2016-03-29 | 4 | Gould Terry P By Fund | CRVS | Common Stock, $0.0001 par value | I | 95 001 | 662 122 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | Gould Terry P By Fund | CRVS | Common Stock, $0.0001 par value | I | 567 121 | 567 121 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | Gould Terry P By Fund | CRVS | Common Stock, $0.0001 par value | I | 15,0000 | 51 712 | 776 | 694 854 | ||||
| 2016-03-29 | 2016-03-29 | 4 | Gould Terry P By Fund | CRVS | Common Stock, $0.0001 par value | I | 92 278 | 643 142 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | Gould Terry P By Fund | CRVS | Common Stock, $0.0001 par value | I | 550 864 | 550 864 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | MILLER RICHARD A MD By Trust | CRVS | Series B Preferred Stock | I | −62 455 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | MILLER RICHARD A MD By Trust | CRVS | Series A Preferred Stock | I | −266 310 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 62 455 | 1 046 993 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 266 310 | 984 538 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Series B Convertible Preferred Stock | I | −97 746 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Series A Convertible Preferred Stock | I | −583 510 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Series B Convertible Preferred Stock | I | −71 863 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Series A Convertible Preferred Stock | I | −428 998 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Series B Convertible Preferred Stock | I | −95 001 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Series A Convertible Preferred Stock | I | −567 121 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Series B Convertible Preferred Stock | I | −92 278 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Series A Convertible Preferred Stock | I | −550 864 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Common Stock, $0.0001 par value | I | 15,0000 | 54 777 | 822 | 736 033 | ||||
| 2016-03-29 | 2016-03-29 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Common Stock, $0.0001 par value | I | 97 746 | 681 256 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Common Stock, $0.0001 par value | I | 583 510 | 583 510 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Common Stock, $0.0001 par value | I | 15,0000 | 40 272 | 604 | 541 133 | ||||
| 2016-03-29 | 2016-03-29 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Common Stock, $0.0001 par value | I | 71 863 | 500 861 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Common Stock, $0.0001 par value | I | 428 998 | 428 998 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Common Stock, $0.0001 par value | I | 15,0000 | 53 239 | 799 | 715 361 | ||||
| 2016-03-29 | 2016-03-29 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Common Stock, $0.0001 par value | I | 95 001 | 662 122 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Common Stock, $0.0001 par value | I | 567 121 | 567 121 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Common Stock, $0.0001 par value | I | 15,0000 | 51 712 | 776 | 694 854 | ||||
| 2016-03-29 | 2016-03-29 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Common Stock, $0.0001 par value | I | 92 278 | 643 142 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | ADAMS STREET PARTNERS LLC By Fund | CRVS | Common Stock, $0.0001 par value | I | 550 864 | 550 864 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | Thompson Peter A. See Footnotes | CRVS | Series B Convertible Preferred Stock | I | −713 776 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | Thompson Peter A. See Footnotes | CRVS | Series A Convertible Preferred Stock | I | −3 994 674 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 15,0000 | 550 000 | 8 250 | 5 258 450 | ||||
| 2016-03-29 | 2016-03-29 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 713 776 | 4 708 450 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | Thompson Peter A. See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 3 994 674 | 3 994 674 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Series B Convertible Preferred Stock | I | −713 776 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Series A Convertible Preferred Stock | I | −3 994 674 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 15,0000 | 550 000 | 8 250 | 5 258 450 | ||||
| 2016-03-29 | 2016-03-29 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 713 776 | 4 708 450 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | ORBIMED ADVISORS LLC See Footnotes | CRVS | Common Stock, $0.0001 par value | I | 3 994 674 | 3 994 674 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | LEA LEIV By Trust | CRVS | Series A Preferred Stock | I | −42 608 | 0 | ||||||
| 2016-03-29 | 2016-03-29 | 4 | LEA LEIV By Trust | CRVS | Common Stock, $0.0001 par value | I | 42 608 | 199 253 | ||||||
| 2016-03-24 | 2016-03-22 | 4 | ADAMS STREET PARTNERS LLC See Footnotes | CRVS | Stock Option (Right to Buy) | I | 15,00 | 30 000 | 30 000 | |||||
| 2016-03-24 | 2016-03-22 | 4 | Gould Terry P | CRVS | Stock Option (Right to Buy) | D | 15,00 | 30 000 | 30 000 | |||||
| 2016-03-24 | 2016-03-22 | 4 | Thompson Peter A. | CRVS | Stock Option (Right to Buy) | D | 15,00 | 30 000 | 30 000 | |||||
| 2016-03-24 | 2016-03-22 | 4 | MILLER RICHARD A MD | CRVS | Stock Option (Right to Buy) | D | 15,00 | 500 000 | 500 000 | |||||
| 2016-03-24 | 2016-03-22 | 4 | Verner Erik J. | CRVS | Stock Option (Right to Buy) | D | 15,00 | 60 000 | 60 000 | |||||
| 2016-03-24 | 2016-03-22 | 4 | Jones William Benton | CRVS | Stock Option (Right to Buy) | D | 15,00 | 60 000 | 60 000 | |||||
| 2016-03-24 | 2016-03-22 | 4 | Krognes Steve E. | CRVS | Stock Option (Right to Buy) | D | 15,00 | 30 000 | 30 000 | |||||
| 2016-03-24 | 2016-03-22 | 4 | LEA LEIV | CRVS | Stock Option (Right to Buy) | D | 15,00 | 60 000 | 60 000 | |||||
| 2016-03-22 | 3 | LEA LEIV By Trust | CRVS | Common Stock, $0.0001 par value | I | 313 290 | ||||||||
| 2016-03-22 | 3 | LEA LEIV By Trust | CRVS | Common Stock, $0.0001 par value | I | 313 290 | ||||||||
| 2016-03-22 | 3 | Verner Erik J. | CRVS | Common Stock, $0.0001 par value | D | 127 546 | ||||||||
| 2016-03-22 | 3 | Verner Erik J. | CRVS | Common Stock, $0.0001 par value | D | 127 546 | ||||||||
| 2016-03-22 | 3 | Jones William Benton | CRVS | Common Stock, $0.0001 par value | D | 227 546 | ||||||||
| 2016-03-22 | 3 | Jones William Benton | CRVS | Common Stock, $0.0001 par value | D | 227 546 | ||||||||
| 2016-03-22 | 3 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 1 436 456 | ||||||||
| 2016-03-22 | 3 | MILLER RICHARD A MD By Trust | CRVS | Common Stock, $0.0001 par value | I | 1 436 456 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
